QA102 / MingMed Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QA102 / MingMed Biotech
AMEND, NCT05536752: QA102 Phase II Study in Subjects With Dry AMD

Active, not recruiting
2
145
US
QA102/Placebo, QA102, Placebo
Smilebiotek Zhuhai Limited
Dry Age-related Macular Degeneration
01/25
01/25

Download Options